Trial intelligence / Profile preview

Umbilical cord stromal mesenchymal cell intra-articular transplantation for knee osteoarthritis

IRCT20211102052944N1Phase 2Completed

Sponsor
Royan Cord Blood Bank
Start
Nov 2021
Countries
1
01

Overview

Phase 2, single-blind trial of hyaluronic acid in knee osteoarthritis (OA) (2 arms), sponsored by Royan Cord Blood Bank. Primary endpoints: Adverse events, Serious adverse events and 4 more. Started Nov 2021; status: completed.

02

Drugs

hyaluronic acid
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on IRCT20211102052944N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211102052944N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call